Mutational analyses of the AML1 gene in patients with myelodysplastic syndrome - Wikidata - awgldk - TriplyDB

Mutational analyses of the AML1 gene in patients with myelodysplastic syndrome

Mutational analyses of the AML1 gene in patients with myelodysplastic syndrome

http://www.wikidata.org/entity/Q28217097

about

sameAs

Lymphoid enhancer factor-1 links two hereditary leukemia syndromes through core-binding factor alpha regulation of ELA2.RUNX1 mutations are frequent in chronic myelomonocytic leukemia and mutations at the C-terminal region might predict acute myeloid leukemia transformation.

P2860

Q38519020-DFB88EDE-11C9-496D-9CD8-4C5ACA8F3887 Q51771337-A5B223A7-264D-4AC8-A539-0195EDABA95E

P2860

Mutational analyses of the AML1 gene in patients with myelodysplastic syndrome

http://www.wikidata.org/entity/Q28217097

description

2002 nî lūn-bûn

@nan

2002 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի մարտին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Mutational analyses of the AML1 gene in patients with myelodysplastic syndrome

@ast

Mutational analyses of the AML1 gene in patients with myelodysplastic syndrome

@en

Mutational analyses of the AML1 gene in patients with myelodysplastic syndrome

@nl

type

label

Mutational analyses of the AML1 gene in patients with myelodysplastic syndrome

@ast

Mutational analyses of the AML1 gene in patients with myelodysplastic syndrome

@en

Mutational analyses of the AML1 gene in patients with myelodysplastic syndrome

@nl

prefLabel

Mutational analyses of the AML1 gene in patients with myelodysplastic syndrome

@ast

Mutational analyses of the AML1 gene in patients with myelodysplastic syndrome

@en

Mutational analyses of the AML1 gene in patients with myelodysplastic syndrome

@nl

P1433

Q28217097-EC37A119-BF99-4588-9DB6-C2AA35949E06

P1476

Q28217097-382C218F-F7B6-44A3-8B46-2A1DEEF52C85

P2093

Q28217097-14FDF248-C8A2-4115-90B2-893E179336D2

Q28217097-3E4835C3-27D7-46F6-873E-57089A2A214D

Q28217097-3FEDC262-2550-4F49-A403-9CE7F27873BC

Q28217097-667557EE-E626-4826-A033-8278552DC612

Q28217097-98FBB3B5-A31D-4AA8-9913-C79EC056D74C

Q28217097-B46D8FD2-2B93-465C-BA6C-A00FC89176E4

Q28217097-BCDDF897-B52C-4BCF-8304-3355E90095FC

Q28217097-F8D4605C-5C29-4395-868A-9CE5C18C40D3

P2860

Q28217097-09A449A3-5FA6-4FFF-8A8F-3B3E44D54229

Q28217097-424F327F-6506-42FF-9B0C-6B7FB84A92F4

Q28217097-62BC35AA-9E50-4ED7-AECA-EFA010337B29

Q28217097-6C45462F-8F0D-4AAB-A14B-5F8BA1F8D7D2

Q28217097-7F0360BE-FCDC-4315-BF89-E353C42CE7E4

Q28217097-8744ADC9-B71B-41F8-9587-BC2CC38551BA

Q28217097-8C78ABF0-28A1-4B22-B7CA-15CCFB6F6CFE

Q28217097-8D16A83F-4F53-4842-8B3E-E8947AFCDA4C

Q28217097-A0EAA37F-2021-440B-BE3D-1989992E2CAE

Q28217097-A57AEE5B-929F-45D9-B3E7-A20104082442

P304

Q28217097-06EF0681-7E9E-42D6-8989-FDDF19F6E985

P31

Q28217097-60B6EC35-011F-4F44-ACCD-67963A6CAC2A

P356

Q28217097-92B656FA-BCAB-40B7-A474-653DE0598E4B

P407

Q28217097-79267595-3C37-4885-A333-DCC20799D1F7

P433

Q28217097-97A7FF2E-B573-478C-9F21-854C16F48DC9

P478

Q28217097-BF91C3A5-3351-4C00-8D9B-CE8FC2AA7E18

P50

Q28217097-53F642CB-B889-488A-8A5B-636C4B9B4169

P577

Q28217097-E6F3E79E-6774-4C03-99D2-E9E5231F60C6

P698

Q28217097-89AC79B1-14A7-40C6-BB6C-460387363B06

P356

10428190290012155

P1433

Leukemia & Lymphoma

P1476

Mutational analyses of the AML1 gene in patients with myelodysplastic syndrome

@en

P2093

Akira Hangaishi

http://www.w3.org/2001/XMLSchema#string

Hisamaru Hirai

http://www.w3.org/2001/XMLSchema#string

Kazuhiro Maki

http://www.w3.org/2001/XMLSchema#string

Kinuko Mitani

http://www.w3.org/2001/XMLSchema#string

Mineo Kurokawa

http://www.w3.org/2001/XMLSchema#string

Oich Imai

http://www.w3.org/2001/XMLSchema#string

Seishi Ogawa

http://www.w3.org/2001/XMLSchema#string

Shigeru Chiba

http://www.w3.org/2001/XMLSchema#string

P2860

Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia

Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions

The 3;21 translocation in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER 1

Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia

AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis

A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome

Dimerization with PEBP2beta protects RUNX1/AML1 from ubiquitin-proteasome-mediated degradation

Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions

Hematopoiesis in the fetal liver is impaired by targeted mutagenesis of a gene encoding a non-DNA binding subunit of the transcription factor, polyomavirus enhancer binding protein 2/core binding factor

Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia.

P304

617-621

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10428190290012155

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12002768

http://www.w3.org/2001/XMLSchema#string